ANVSVSCLOV• 6 Months (Normalized)
ANVS vs CLOV (Annovis Bio Inc. vs Clover Health Investments Corp.)
Showing Closing Date Range from Mar, 19 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANVS Performance $1.14
-57.3%
Annovis Bio Inc.
Normalized Baseline0.00%
CLOV Performance $4.69
+148.14%
Clover Health Investments Corp.
Normalized Baseline0.00%
Alpha Spread Margin CLOV LEADS
-205.44%
CLOV outperforming by 205.44%
ANVSCLOV
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANVS CLOV
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | ANVS Price | ANVS Gain (%) | CLOV Price | CLOV Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $1.14 | -57.30% | $4.69 | +148.14% | -205.44% |
| Sep 14, 2026 | $1.14 | -57.30% | $5.10 | +169.84% | -227.14% |
| Sep 11, 2026 | $1.12 | -58.05% | $4.82 | +155.03% | -213.08% |
| Sep 10, 2026 | $1.19 | -55.43% | $4.71 | +149.21% | -204.64% |
| Sep 09, 2026 | $1.22 | -54.31% | $4.34 | +129.63% | -183.94% |
| Sep 08, 2026 | $1.30 | -51.31% | $4.29 | +126.98% | -178.29% |
| Sep 04, 2026 | $1.39 | -47.94% | $4.26 | +125.13% | -173.07% |
| Sep 03, 2026 | $1.38 | -48.31% | $4.26 | +125.13% | -173.44% |
| Sep 02, 2026 | $1.70 | -36.33% | $4.30 | +127.51% | -163.84% |
| Sep 01, 2026 | $1.69 | -36.70% | $4.30 | +127.51% | -164.21% |
| Aug 31, 2026 | $1.72 | -35.58% | $4.15 | +119.58% | -155.16% |
| Aug 28, 2026 | $1.72 | -35.58% | $4.23 | +123.81% | -159.39% |
| Aug 27, 2026 | $1.81 | -32.21% | $4.23 | +123.81% | -156.02% |
| Aug 26, 2026 | $1.78 | -33.33% | $4.25 | +124.87% | -158.20% |
| Aug 25, 2026 | $1.82 | -31.84% | $4.13 | +118.52% | -150.36% |
Page 1 of 9